Results 91 to 100 of about 4,628,365 (239)
Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley +1 more source
Unlocking the potential of cell‐permeable nanobodies for intracellular applications
This review outlines current strategies for delivery of nanobodies into cells and highlights recent examples of functional applications. By addressing and manipulating intracellular targets, these molecules hold great potential for treating cancer, respiratory diseases and neurological disorders, making this a vibrant area of research in the biomedical
Mariona Gené‐Verdés +2 more
wiley +1 more source
Comparing the paths of Hedgehog release in artificial and natural settings
Hh morphogens require solubilization factors to overcome their tight association with the plasma membrane and signal to distant cells, but the precise functions of these factors are controversial. Here, we use published in vivo observations as the most relevant evidence to test their suggested functions and discuss contradictions and gaps between in ...
Janna Puschmann, Kay Grobe
wiley +1 more source
How structural disorder and polyelectrolyte properties of prothymosin α enable its large interactome
In this review, complexes of the fully disordered and highly negatively charged prothymosin α are collected, described, and discussed. Linked to its poly‐electrostatic character, prothymosin α engages a large interactome through multiple different binding modes ranging from fully disordered complexes to short linear motif (SLiM)‐driven interactions ...
Ketty C. Tamburrini +3 more
wiley +1 more source
Synthetic single‐domain antibodies as immunoconjugate therapeutics
Single‐domain antibodies (sdAbs), at about one‐tenth the size of conventional antibodies, overcome the traditional barrier of deeper penetration into tumors. Their small footprint and ease of engineering facilitate transport of cytotoxic payloads or radionuclides directly to cancer cells.
Robbins Puthenveetil +8 more
wiley +1 more source
Realizing stable categories as derived categories
In this paper, we discuss a relationship between representation theory of graded self-injective algebras and that of algebras of finite global dimension. For a positively graded self-injective algebra $A$ such that $A_0$ has finite global dimension, we construct two types of triangle-equivalences.
openaire +3 more sources
Cell‐fate decisions emerge from groups of genes that cooperate within a group and inhibit competing groups. Two‐team networks generate stable cell states and consistent transitions. Adding a third competing team produces more complex landscapes, more hybrid states, and less predictable transitions between cell states.
Kushal Haldar +5 more
wiley +1 more source
Localization of triangulated categories and derived categories
In this paper, the author considers triangulated categories and derived categories from the point of view of localization of abelian categories. The paper is organized as follows. Section 1 is dedicated to preliminaries. Sections 2-3 contain the localization of triangulated categories (there is also studied the relation between localization and stable \
openaire +2 more sources
Mitochondrial translation and coordinated cytosolic translation in metabolic homeostasis and disease
Mitochondrial function depends on coordinated protein production from the nuclear and mitochondrial genomes. This review highlights how cytosolic and mitochondrial translation, mRNA localization, protein import, and respiratory complex assembly are integrated to maintain mitochondrial proteostasis and function.
Boseon Kim +4 more
wiley +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source

